Clinical trial
Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: A Multicenter Phase II Trial (The STRONG 2 Trial)
NCT06493734 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: A Multicenter Phase II Trial (The STRONG 2 Trial)
- Lead sponsor
- Erasmus Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2024
- Completion date
- March 1, 2028
- Enrollment
- 30 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.